These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31987851)

  • 1. A Systematic Safety Evaluation of Nanoporous Mannitol Material as a Dry-Powder Inhalation Carrier System.
    Zhang X; Yue X; Cui Y; Zhao Z; Huang Y; Cai S; Wang G; Wang W; Hugh S; Pan X; Wu C; Tan W
    J Pharm Sci; 2020 May; 109(5):1692-1702. PubMed ID: 31987851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance.
    Zhao Z; Wang G; Huang Z; Huang Y; Chen H; Pan X; Zhang X
    AAPS PharmSciTech; 2022 Jun; 23(5):164. PubMed ID: 35697949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
    Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.
    Pinto JT; Zellnitz S; Guidi T; Schiaretti F; Schroettner H; Paudel A
    Pharm Res; 2021 Jun; 38(6):1107-1123. PubMed ID: 34114162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.
    Hou A; Li L; Huang Y; Singh V; Zhu C; Pan X; Quan G; Wu C
    Drug Deliv Transl Res; 2018 Jun; 8(3):693-701. PubMed ID: 29600480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W; Nokhodchi A
    Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
    Odziomek M; Sosnowski TR; Gradoń L
    Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
    Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
    Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focusing on powder processing in dry powder inhalation product development, manufacturing and performance.
    Stegemann S; Faulhammer E; Pinto JT; Paudel A
    Int J Pharm; 2022 Feb; 614():121445. PubMed ID: 34998921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation.
    Peng T; Zhang X; Huang Y; Zhao Z; Liao Q; Xu J; Huang Z; Zhang J; Wu CY; Pan X; Wu C
    Sci Rep; 2017 May; 7():46517. PubMed ID: 28462948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement.
    Zhao Z; Huang Z; Zhang X; Huang Y; Cui Y; Ma C; Wang G; Freeman T; Lu XY; Pan X; Wu C
    Expert Opin Drug Deliv; 2018 May; 15(5):443-457. PubMed ID: 29532682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of void forming index (VFI): Detection of the effect of physical properties of dry powder inhaler formulations on powder cohesion.
    Maruyama S; Ando S; Yonemochi E
    Int J Pharm; 2020 Oct; 588():119766. PubMed ID: 32800937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical stability of dry powder inhaler formulations.
    Shetty N; Cipolla D; Park H; Zhou QT
    Expert Opin Drug Deliv; 2020 Jan; 17(1):77-96. PubMed ID: 31815554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.